CLCS · Cell Source, Inc. · Financials
$0.40
At close · Oct 21
Return incl. dividend (before tax)
Going-concern doubt
— flagged May 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“During the three months ended March 31, 2025, we did not generate any revenues, incurred a net loss of approximately $1,482,000 and used cash in operations of approximately $600,000. As of March 31, 2025, we had a working capital deficiency of approximately $20,136,000 and an accumulated deficit of approximately $47,662,000. As of March 31, 2025 and through the date of this filing, notes payable with principal amounts totaling approximately $6,328,000 and $11,116,000, respectively, were past due. We will continue to incur net operating losses to fund operations. These conditions raise substantial doubt about our ability to continue as a going concern for at least one year from the date these financial statements are issued.”View the 10-Q filed May 14, 2026
Market Cap
$27.18M
Shares
67.95M
Volume · Oct 21
602
Avg daily vol (3M)
3397
Income-statement, balance-sheet and cash-flow figures from SEC filings, plus a debt profile anchored in the latest 10-K and updated by each 10-Q and debt exhibit.
Net Income
-$4.51M
+15.2%
FY2024
Diluted EPS
-$0.14
+17.6%
FY2024
Operating Cash Flow
-$2.68M
-14.3%
FY2024
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| — | — | — | $1.94M | $1.27M | $834.94K | $2.46M | $274.94K | $637.32K | $554.19K | $392.93K | $806.16K | $351.51K | |
| $1.64M | $1.94M | $2.6M | $2.18M | $2.7M | $2.64M | $1.17M | $1.28M | — | — | — | — | $1268 | |
| $1.23M | — | — | — | — | — | — | $1.28M | $815.95K | $951.78K | $1.1M | $2.24M | $319.86K | |
| $3.7M | $3.84M | $4.33M | $4.18M | $4.02M | $3.64M | $3.81M | $2.01M | $2.29M | $2.32M | $2.32M | $4.05M | $1.46M | |
| -$3.7M | -$3.84M | -$4.33M | -$4.18M | -$4.02M | -$3.64M | -$3.81M | -$2.01M | -$2.29M | — | — | — | — | |
| — | — | — | — | — | $457.37K | $228.84K | -$219.12K | $174.97K | $243.43K | $32.61K | $674 | $681.78K | |
| -$1.02M | -$672.4K | -$995.87K | -$992.42K | -$1.45M | -$922.13K | -$670.29K | -$111.3K | -$789.71K | $1.35M | -$183.63K | -$3413 | -$328.28K | |
| — | -$4.51M | -$5.32M | -$5.17M | -$5.47M | -$4.56M | -$4.48M | -$2.12M | -$3.32M | -$967.78K | -$3.08M | -$4.06M | -$25.63K | |
| — | — | — | — | — | $0 | $0 | — | $0 | $0 | $0 | $0 | $0 | |
| -$4.72M | -$4.51M | -$5.32M | -$5.17M | -$5.47M | -$4.56M | -$4.48M | -$2.12M | -$3.08M | -$967.78K | -$2.5M | -$4.06M | -$1.78M | |
| -$6.12M | -$5.89M | -$6.55M | -$6.33M | -$6.45M | -$5.44M | -$5.22M | -$2.57M | — | — | — | — | — | |
| USD/shares | -$0.14 | -$0.14 | -$0.17 | -$0.18 | -$0.19 | — | — | — | — | — | — | — | — |
| USD/shares | -$0.14 | -$0.14 | -$0.17 | -$0.18 | -$0.19 | — | — | — | — | — | — | — | — |
| shares | — | 41.87M | 37.79M | 34.84M | 33.12M | 29.1M | 28.33M | 27.55M | 26.77M | 26.19M | 25.72M | 22.19M | 13.17M |
| shares | — | 41.87M | 37.79M | 34.84M | 33.12M | 29.1M | 28.33M | 27.55M | 26.77M | 26.19M | 25.72M | 22.19M | 13.17M |
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Debt Profile
Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.
Reported debt balances
Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.
| Reported balance | As of | Amount | Source |
|---|---|---|---|
| Current finance lease liabilities | 2025-03-31 | USD 314,985 | 10-Q filed 2026-05-14 |
Instrument and agreement coverage is incomplete. Additional filings are awaiting review.
Covenants
Covenant terms have not yet been verified for this profile.
The balance figures do not establish whether covenants apply or whether the company complies with them.
Loans, facilities and notes
The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.